 LexaGene Holdings Inc TSX-V:LXG, OTCQB:LXXGF announced that its MiQLab automated rapid pathogen testing device has successfully completed tests for biothreat agents including anthrax and plague as part of a research agreement with the US Army. MiQLab was used on reagents from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defenses JPEO-CBRND Joint Project Lead for CBRND Enabling Biotechnologies JPL CBRND EB Defense Biological Product Assurance Office DBPAO to successfully detect biothreat agents such as Bacillus anthracis and Yersinia pestis in under a minute, the company said. 